Biomarkers of suppressed natural killer (NK) cell function in metastatic melanoma: Decreased NKG2D and increased CD158a receptors on CD3–CD16+ NK cells
Authors:
- Gordana KonjevićGKGordana Konjević
- Vladimir JurišićVladimir Jurišić
- Ivan SpužićISIvan Spužić
- 13 March 2009
- journal article
- research article
- Published by Taylor & Francis in Biomarkers
- Vol. 14 (4) , 258-270
Abstract
In metastatic melanoma (MM) patients we evaluated natural killer (NK)-cell activity, distribution of several NK receptors and their correlation with NK function. Peripheral blood lymphocytes (PBL) of MM patients and controls were analysed for NK activity and expression of activating NKG2D, CD161 and KIR, CD158a and CD158b receptors on CD3–CD16+ NK cells. MM patients not only had significantly decreased NK activity and NK-cell interferon (IFN)-γ production, a redistribution of NK-cell subsets with an increase in CD16dim and a reduction in CD16bright NK subsets. There was a decreased CD161 and NKG2D and an increased CD158a NK-cell expression in MM patients, with a positive correlation between NKG2D expression and NK cytotoxicity and an inverse correlation between CD158b expression and NK-cell cytotoxicity in patients. Furthermore, patients’ CD3-CD16bright NK subset showed lower expression of CD161 and CD158a. Therefore, NKG2D, CD158a and CD158b expression in MM patients may represent several clinically useful ‘biomarkers’ of suppressed NK function.Keywords
This publication has 71 references indexed in Scilit:
- NK cells: New issues and challengesEuropean Journal of Immunology, 2008
- Inhibitory Receptor Signaling via Tyrosine Phosphorylation of the Adaptor CrkImmunity, 2008
- Human natural killer cellsBlood, 2008
- In Vivo Expression Pattern of MICA and MICB and Its Relevance to Auto-Immunity and CancerPLOS ONE, 2007
- Reduced natural killer (NK) function associated with high-risk myelodysplastic syndrome (MDS) and reduced expression of activating NK receptorsBlood, 2007
- Low expression of CD161 and NKG2D activating NK receptor is associated with impaired NK cell cytotoxicity in metastatic melanoma patientsClinical & Experimental Metastasis, 2007
- MHC class I molecules and kirs in human history, health and survivalNature Reviews Immunology, 2005
- Mini‐review: Defense strategies and immunity‐related genesEuropean Journal of Immunology, 2003
- A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunityEuropean Journal of Immunology, 2003
- NATURAL KILLER CELLS IN ANTIVIRAL DEFENSE: Function and Regulation by Innate CytokinesAnnual Review of Immunology, 1999